106
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Predictive value of early second trimester maternal serum cyclophilin A concentrations in women complicated with preeclampsia: a preliminary case–control study

ORCID Icon & ORCID Icon
Pages 387-392 | Received 28 Feb 2020, Accepted 28 May 2020, Published online: 07 Jun 2020
 

ABSTRACT

Objective

To investigate cyclophilin A in early second trimester of pregnancy before the onset of preeclampsia.

Methods

In this prospective case-control study, 51 pregnant women whose serum were collected and stored and who developed preeclampsia in later follow-up and 41 pregnant women as control group were included.

Results

Maternal serum cyclophilin A levels in the study group who developed preeclampsia in later follow-up were significantly higher than those of normal healthy pregnant women.

Conclusion

Cyclophilin A may be a valuable predictor for pregnant women who subsequently develop preeclampsia in their pregnancies.

Data availability statement

All relevant clinical and biological data are available within the article, or available from the authors upon a reasonable request.

Disclosure statement

All the authors declare there are no potential conflicts of interest exist with respect to the research, authorship, and/or publication of this article.

Additional information

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.